|
Can we meet the Global Fund's ambitions to cut malaria deaths by 64 percent?
|
|
Last week, the Global Fund to Fight AIDS, Tuberculosis and Malaria reached a record US$14.25 billion in donor pledges at its Seventh Replenishment conference – with ambitions to cut malaria deaths by 64 percent over its 2023-25 funding cycle.
This critical financing mechanism has invested over US$55 billion in the past 20 years to deliver, and scale-up, a range of high-impact interventions, accelerating efforts to end these diseases in endemic countries. In the fight against malaria, this has included measures to improve case management, strengthen health systems and deliver mass campaigns such as net distribution and chemoprevention.
Whilst news of the impressive trial results of the R21/Matrix-M malaria vaccine brings hope, the global burden of malaria cases still stands at 241 million, and the Global Fund is still to meet its target of $US18 billion. The UK has not yet pledged, historically one of Global Fund's largest public donors, and it looks likely its funding commitment will be less than hoped for.
Read on to find out more about what is needed to enable countries to regain momentum to accelerate their progress along the path to malaria elimination, and the latest updates from our news, blog and publications.
|
|
|
UK must move quickly to match commitments of allies at Global Fund conference
|
|
|
Many African countries, hit hard by the COVID-19 pandemic, increased their pledges for the Global Fund this month. The UK, yet to pledge, has the opportunity to close the US$3.75 billion funding gap and help end malaria.
|
|
|
The impact of Global Fund investment in fighting malaria
|
|
|
20 years on from its inception, the Global Fund has helped to save 44 million lives. To mark the Seventh Replenishment, we looked back at the impact it's had on fighting malaria across Africa and Asia and the critical role this investment plays.
|
|
|
Developing African research networks and training opportunities for capacity-strengthening in Arbovirus surveillance and response
|
|
|
This webinar, presented by the Resilience Against Future Threats (RAFT) project, examined the state-of-readiness of Africa to confront current and future arbovirus threats. Click on the link below to watch the recording.
|
|
|
Genomic surveillance used to improve malaria treatment in Mozambique
Through a new project, GenMoz, health workers in Mozambique are collecting samples of malaria parasites to monitor malaria transmission intensity and reduce resistance to antimalarial drugs and diagnostics – a global challenge for disease control and elimination.
|
|
|
|
R21 malaria vaccine gives up to 80 percent protection
Scientists at the University of Oxford develop a remarkable new malaria vaccine, demonstrating up to 80 percent efficacy. This meets the World Health Organization’s 75 percent efficacy goal and adds a valuable contribution to the effective interventions against malaria.
|
|
|
|
Eliminating malaria in the Greater Mekong Subregion
The Greater Mekong Subregion – a vast geography in Asia, home to 300 million residents connected by the Mekong River – is on track to eliminate malaria by 2030. Find out how the region achieved this success and what can be learnt from the transition from control to elimination.
|
|
|
Implementing reactive malaria surveillance in low transmission areas: Insights from Mozambique
Following our project, we assessed the feasibility of including reactive surveillance activities in malaria programming in two districts of low malaria transmission and incidence in Maputo province, Mozambique.
|
|
|
Sustaining the data-to-action transition in Mozambique: Lessons learnt from the third year of strengthening malaria surveillance
In collaboration with our project partners, we implemented a range of activities to improve surveillance data quality and to enhance the use of data for decision-making in Mozambique.
|
|
|
Using the role model approach to improve malaria prevention and control: Lessons from Ethiopia
Through our recent project in Ethiopia, we sought to improve understanding and uptake of malaria interventions, using a behaviour change communication approach built on the existing strengths of the community.
|
|
|
Capacity statement – French and Portuguese
Our evidence-based, social and behaviour change communication activities combat targeted diseases, encourage ownership of health issues, improve public health outcomes and promote universal health coverage across Africa and Asia.
|
|
Project brief – Portuguese
Through the GenMoz project in Mozambique, we seek to support malaria control and elimination by monitoring the genetic markers of the Pf parasite that indicate resistance to antimalarial drugs and diagnostics.
Read now
|
Learning brief – Portuguese
Mozambique is creating a data-to-action culture for malaria programme management. We have gathered lessons learnt from the second year of implementing effective surveillance activities for malaria control.
Read now
|
|
|
Copyright © 2022 Malaria Consortium, All rights reserved.
|
|
|
|
|
|
